Vol. 3 No. 2 (2022): Journal of Pharmacovigilance and Drug Research

View Vol. 3 No. 2 (2022): Journal of Pharmacovigilance and Drug Research

Published: 2022-06-01

Research Articles

Knowledge, attitude and practice towards adverse drug events reporting among graduating health science students of college of health sciences, Addis Ababa University, Ethiopia

Mamo Senbeta, Hiluf Maldey, Melak Gedamu (Author)

27-33
- PDF

Editorial

The need for Quality

Erika Barbarosie (Author)

1-3
- PDF

Case Studies

Lymphoproliferative skin lesion as a previously unreported adverse event detected in a patient receiving mSTR TB treatment

Hakob Atshemyan, Naira Khachatryan, Artak Manukyan, Anush Khachatryan, Alvard Poghosyan (Author)

34-37
- PDF
Safety profile and adverse drug reaction with causality assessment of Dapagliflozin in diabetes

Prabhudatta Mohapatra, Karmajeet Rath, Priyabrata Pattanayak (Author)

38-40
- PDF
Safety profile and adverse drug reactions with causality assessment of Ticagrelor in Myocardial Infraction

S. P. Santhosh Kumar, Shangavi V, Abisha R. S., Aiswaria M. S., Abburi Lalitha Nandini, Abitha Aravindakshan, Amritha Harish N (Author)

41-45
- PDF

Review Articles

Safety and tolerability of antipsychotic drugs in pediatric patients

Nabih Lawand, Samaa Al Tabbah (Author)

4-10
- PDF
Drug development hit by war

Hara Prasad Mishra, Ayush Goel, Sahil Kumar, Mihir Chauhan, Mrinal Patnaik, Imaad Rehman (Author)

11-15
- PDF
Exploring position of colchicine in management of COVID 19 – A systematic review

Shambo Samrat Samajdar, Shrestha Dutta, Aneek Ghosh, Shatavisa Mukherjee, Jayanta Sharma, Anwesha Behera, Oyendrilla Mitra, Ishanee Das Sharma, Mohojit Chakraborty, Santanu K Tripathi (Author)

16-21
- PDF
Anti-viral activity of Withania somnifera phytoconstituents against corona virus (SARS-COV-2)

Shweta Parihar (Author)

22-26
- PDF